Labiotech.eu

More News! 15 Nov 2018

Soldier Bug Could Help Combat Antibiotic Resistance

A garden insect makes a molecule that attacks the cell wall of bacteria, providing a new potential weapon in the fight against antibiotic resistance. Thanatin is a peptide molecule produced by the spined soldier bug Podisus maculiventris to control the types of bacteria that live in its gut. A research group from the University of Zurich […]

November 15, 2018 - 2 minutesmins - By Jonathan Smith

Inside Labiotech 15 Nov 2018

Biotech Money Insider – A Year of Investments in Europe

Did you ever dream of having access to all the recent investments in the European Biotech space? Well, I did! That’s why we created Biotech Money Insider, the first book by Labiotech.eu. Since we launched our website, back in 2014, we gathered data on over 1000 active biotech companies in Europe. This year, we decided […]

November 15, 2018 - 1 minutemin - By Joachim Eeckhout

united neuroscience parkinsons disease cover

News and Trends 14 Nov 2018

Parkinson’s Disease Vaccine Shows Preclinical Promise

The biotech company United Neuroscience has developed a candidate Parkinson’s disease vaccine that targets a protein linked to the condition. The vaccine teaches the immune system to attack aggregations of alpha-synuclein. When this protein aggregates in neurons, it can lead to several neurodegenerative disorders, including Parkinson’s. In United Neuroscience’s preclinical study, the vaccine was able to prevent the […]

November 14, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 14 Nov 2018

CAR-T Promise for Patients with Solid Tumors

A new CAR-T cancer therapy from the Belgian company Celyad has shown early positive results against solid tumors in two Phase I trials, including one trial that did not include add-on chemotherapy. In one ongoing Phase I trial, Celyad’s CAR-T therapy, combined with chemotherapy, successfully shrank tumors in three enrolled patients with aggressive colorectal cancer. One […]

November 14, 2018 - 3 minutesmins - By Jonathan Smith

In Depth 14 Nov 2018

Taking Biotech to the Next Level with Laboratory Automation

Automation is slowly taking over our lives, ranging from smart homes to self-driving cars. With experiments becoming ever more complex and datasets more immense, a question that comes to mind: can we automate biotech research? Most pharma and biotech companies, and in part also academic labs, have automated sections of their processes and make use […]

November 14, 2018 - 6 minutesmins - By Melanie De Almeida

More News! 13 Nov 2018

French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins

The French company Quantum Genomics is developing a first-in-class drug that targets proteins in the brain to lower blood pressure. A Phase IIb trial, run by Quantum Genomics, found that eight weeks of taking its drug significantly lowered blood pressure in patients who were overweight or obese and with high blood pressure. This reduction also […]

November 13, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 13 Nov 2018

Are Recent IPO Delays Bad News for European Biotech?

Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs on the stock markets — is this a sign that biotech stocks are underperforming? Since the end of October, several European biotech companies have delayed their IPOs — including Abacus Medicine on the Frankfurt stock exchange, Themis Bioscience on the […]

November 13, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

More News! 12 Nov 2018

This UK Biotech Wants to Make Antibodies Easy to Swallow

Say goodbye to painful antibody injections. The UK biotech Intract Pharma has received a €1.6M grant to advance oral immunotherapy based on approved antibodies, causing less discomfort for patients. The grant, awarded by public agency Innovate UK, will help Intract develop oral versions of existing antibody therapies. This could make the treatments easier for patients […]

November 12, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 10 Nov 2018

Stelarc — Making Art out of the Human Body

From implanting a third ear on his arm to connecting his senses to the internet, Stelarc is an artist known for extreme performances that take the human body to the limit and blur the lines between technology and ourselves. On the inside of his left arm, Stelarc is in the process of ‘growing’ a third […]

November 10, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

Startup Scout 9 Nov 2018

This Biotech Uses Radioactive Chemicals to Diagnose Brain Cancer

In Athens, Greece, we find pro-Actina. This biotech is working on a method to diagnose brain cancer by measuring how ‘leaky’ the brain is. Mission: Founded in 2006, the company is working to improve glioma diagnosis by using a combination of CT scans and an injectable radioactive chemical tracer. Gliomas are the most common forms […]

November 9, 2018 - 3 minutesmins - By Jonathan Smith

huntingtons epigenetics oxford biodynamics

News and Trends 8 Nov 2018

Epigenetics Test Can Distinguish Between Huntington’s Disease Stages

A study run by Oxford BioDynamics suggests that we could predict Huntington’s more easily by analyzing epigenetic changes in the patient’s DNA. Epigenetics describes the way that the expression of our genes is regulated, often influenced by environmental exposure, without changing the genetic code. Ways of modifying gene expression include attaching chemical groups to DNA […]

November 8, 2018 - 2 minutesmins - By Jonathan Smith

Claus Crone Fuglsang Novozymes Industrial Biotechnology Bioeconomy

Interview 8 Nov 2018

How Industrial Biotech is Opening the Way to the Bioeconomy

Biology is helping us find more sustainable solutions to the world’s problems. Claus Crone Fuglsang, Senior VP of Research and Technology at Novozymes, gave me an insight into the rapidly moving field of industrial biotech. Novozymes, the world’s largest producer of industrial enzymes, is one of the oldest players in the field of industrial biotech. […]

November 8, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Soldier Bug Could Help Combat Antibiotic Resistance

Biotech Money Insider – A Year of Investments in Europe

Parkinson’s Disease Vaccine Shows Preclinical Promise

CAR-T Promise for Patients with Solid Tumors

Taking Biotech to the Next Level with Laboratory Automation

French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins

Are Recent IPO Delays Bad News for European Biotech?

This UK Biotech Wants to Make Antibodies Easy to Swallow

Stelarc — Making Art out of the Human Body

This Biotech Uses Radioactive Chemicals to Diagnose Brain Cancer

Epigenetics Test Can Distinguish Between Huntington’s Disease Stages

How Industrial Biotech is Opening the Way to the Bioeconomy

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!